ProKidney Corp (PROK) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts PROK Hot Sheet
Join SI Premium – FREE
ProKidney Corp (NASDAQ: PROK) reported Q2 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $150 thousand versus the consensus estimate of $129.75 thousand.
For earnings history and earnings-related data on ProKidney Corp (PROK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
- Berenberg Upgrades Clariant AG (CLN:SW) (CLZNY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
